October 5, 2020 by Jeffrey Woldt
COVID-19
October 5, 2020, Opinion
The Trump administration’s fitful response to COVID-19 has failed to meet the moment, one in which a pandemic the likes of which has not been seen in a century threatens the well-being and livelihood of millions of Americans. As this issue of Chain Drug Review was about to go to press, more than 6.9 million
October 5, 2020 by David Pinto
Alex Gourlay, John Standley, Stefano Pessina, Walgreens
October 5, 2020, Opinion
Amid the coronavirus pandemic that never seems to end, several stories have captured the attention of those who follow the chain drug community. As of this writing, none is as compelling as the drama at Walgreens, where an ongoing shuffle at the very top levels of management has raised issues and questions for which there
October 5, 2020 by Chain Drug Review
BOPIS, COVID-19
October 5, 2020, Opinion
NEW YORK — According to a new report from Incisiv — “The New Store Shopper in High-Touch Retail” — commissioned by Manhattan Associates, digital is now the front door to the store. COVID-19, the report concludes, has brought radical change to the retail industry, not least a reprioritization of the store experience for pandemic-era shoppers.
September 23, 2020 by Jeffrey Woldt
Dark & Lovely, L’Oréal USA Consumer Products division, Nathalie Gerschtein
Leading Headlines, September 21, 2020, Supplier News
The outbreak of COVID-19 at the start of the year and subsequent efforts to control the virus created much uncertainty in the beauty care business, but did little to disturb the preeminence of L’Oréal. Under the direction of president Nathalie Gerschtein, the L’Oréal USA Consumer Products division adapted quickly to changing dynamics in the marketplace,
September 21, 2020 by Todd Huseby, Rodey Wing and Emily Rowe
coronavirus (COVID-19), health care, health care costs, pharmacy benefit manager (PBM)
Pharmacy, September 21, 2020
Today’s retail pharmacies face increasing pressure from all fronts. Governments are aiming to reduce health care costs, and public sentiment is pushing the industry toward a value-based model. The use of high-cost specialty drugs is increasing dispensing complexity and shifting channel volume — at a time when disruptors like Amazon are poised to impact pricing.
September 21, 2020 by Chain Drug Review
Jeff Leger, Shoppers Drug Mart
News, September 21, 2020
TORONTO — Jeff Leger, president of Shoppers Drug Mart, Canada’s largest drug chain, discussed recent developments at the company including the launch of Shoppers’ first freestanding health clinic, the retailer’s innovative home health care and beauty clinic formats with Chain Drug Review editor-in-chief, Jeffrey Woldt, in a video forum hosted by CDR and sister publication
September 21, 2020 by Chain Drug Review
COVID-19 vaccine
News, September 21, 2020
NEW YORK — The effort to develop a safe and effective vaccine for COVID-19 has been an all-hands-on-deck approach ever since the virus began wreaking havoc across the globe earlier this year. But it seems now, with the presidential election less than two months away — and with President Trump promising a vaccine “very soon”
September 21, 2020 by Chain Drug Review
COVID-19, COVID-19 vaccine, Department of Health and Human Services' (HHS) proposed rule permitting prescription drug importation
News, September 21, 2020
WASHINGTON — The Department of Health and Human Services (HHS) this month authorized pharmacists to order and administer COVID-19 vaccination, a move welcomed by pharmacy advocates. “This is an extremely important decision by the administration,” said National Association of Chain Drug Stores president and chief executive officer Steve Anderson. “When safe and effective COVID-19 vaccinations
September 21, 2020 by David Pinto
John Standley, Stefano Pessina, Walgreens
Opinion, September 21, 2020
As the least-revered year 2020 winds down, several questions emerge regarding the future of chain drug retailing in America. It’s not that the industry is shaky or uncertain going forward; rather it’s that America’s chain drug industry has changed — perhaps permanently. A scenario that was unimaginable a year ago now presents itself as a
September 21, 2020 by Jeffrey Woldt
Doug McMillon, Walmart
Opinion, September 21, 2020
In a recent video marking the first anniversary of the Business Roundtable’s adoption of a revised statement of purpose for a corporation, Walmart CEO Doug McMillon spoke about how the new definition — which was expanded from a tight focus on shareholders to one that also includes customers, employees, suppliers and communities — reflects the
September 21, 2020 by Jeffrey Woldt
global sustainability, Jeffrey Woldt editor-in-chief Chain Drug Review
Opinion, September 21, 2020
CDR SPECIAL REPORT — Since the beginning of the COVID-19 pandemic, the momentum behind the sustainability movement has slowed somewhat, with the attention of government officials, activists and average citizens dominated by the immediate crisis and the concurrent drive for racial justice. The climate emergency has not, however, abated, a reality brought home to Americans
September 9, 2020 by Brian Bossetta
CARES Act, FSAs, HSAs, O-T-Cs
News, September 9, 2020
NEW YORK — A provision in the Coronavirus Aid, Relief and Economic Security (CARES) Act, which Congress passed and President Trump signed into law in March, offers a potential boon to consumers and retailers, according to GlaxoSmithKline (GSK), which is one of the largest providers of over-the-counter medications in the world. The provision in the
September 9, 2020 by Chain Drug Review
COVID-19, CVS
News, September 9, 2020
WOONSOCKET, R.I. — CVS Pharmacy has rolled out back-to-school offerings focusing on strengthening immunity and instilling confidence in children, teens and parents. Whether students are heading back to school with increased safety measures, returning to video-based distance learning or anything in between, implementing new routines can be difficult. As families adjust, CVS is offering all
September 9, 2020 by Jeffrey Woldt
NACDS, NACDS president and chief executive officer Steven Anderson
Opinion, September 9, 2020
Steve Anderson knows a thing or two about leadership, having worked for both a congressman and, during his student days, a member of the British Parliament; run for the House of Representatives; and headed three major trade associations, currently as president and chief executive officer of the National Association of Chain Drug Stores. Recently he